Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Transplantation. 2021 May 1;105(5):999–1007. doi: 10.1097/TP.0000000000003481

Table 1:

Summary of In Vivo Trial Outcomes

Device
Design
Trial
No.
Duration
[days]
Termination Summary Significant Observations
1 1.1 30 Study Completion Thrombosis at lower and upper bearing
1 1.2 28 Study Completion Thrombosis at lower and upper bearing, significant hemolysis
1 1.3 8 Fractured Cannula -
1 1.4 27 Motor Failure Thrombosis at lower and upper bearing, significant hemolysis
2 2.1 2 Animal Welfare Uncontrollable bleeding at arterial line
2 2.2a 30 Study Completion -
2 2.3a 23 Decreasing Bundle Permeability Thrombosis at lower and upper bearing
2 2.4 30 Study Completion -
2 2.5a 30 Study Completion Thrombosis at upper bearing
2 2.6 30 Study Completion Thrombosis at lower and upper bearing
2 2.7a 3 Fractured Cannula -
3 3.1a 30 Study Completion -
3 3.2 4 Animal Welfare Internal bleeding
3 3.3 30 Study Completion -
3 3.4a 10 Increasing Motor Torque Suspected perioperative thrombus ingestion
3 3.5 22 Decreasing Bundle Permeability Thrombosis at lower bearing
3 3.6 30 Study Completion -
3 3.7 28 Study Completion Thrombosis at upper bearing
3 3.8a 14 Animal Welfare Uncontrollable bleeding at cannulation site
a

These trials required a single device exchange within the immediate postoperative period. These exchanges are discussed further within the Discussion section.